In 2021, the Department of Health Government of Australia supported the public funding of TMVr by edge-to-edge repair/tissue approximation using the MitraClip™ system (Abbott Structural, Santa Clara, CA, USA) in patients with moderate-severe or severe symptomatic degenerative (or primary) MR and left ventricular ejection fraction (LVEF) ≥20% who are determined by a Heart Team to be ineligible for surgical intervention.
Accreditation of TMVr Operators by the ATVT Accreditation Committee
Operators and institutions performing transcatheter mitral valve interventions will be formally recognised by the Australian Transcatheter Valve Therapies (ATVT) Accreditation Committee, a committee of Cardiac Accreditation Services Ltd (CASL).